Data‐driven staging of genetic frontotemporal dementia using multi‐modal MRI
暂无分享,去创建一个
G. Frisoni | J. Rowe | A. Danek | R. Vandenberghe | S. Sorbi | Y. Iturria-Medina | D. Galimberti | J. Rohrer | C. Graff | R. Laforce | M. Tartaglia | J. V. van Swieten | B. Borroni | M. Masellis | F. Tagliavini | E. Finger | A. de Mendonça | I. Santana | R. Sánchez-Valle | M. Synofzik | R. Ghidoni | S. Ducharme | H. Seelaar | A. Gerhard | L. Jiskoot | J. Levin | F. Moreno | Jillian McCarthy | C. Butler | M. Otto | Christopher R. Butler | Y. Iturria-medina
[1] Lazaro M. Sanchez-Rodriguez,et al. Integrating molecular, histopathological, neuroimaging and clinical neuroscience data with NeuroPM-box , 2021, Communications biology.
[2] Rebecca M. E. Steketee,et al. Modelling the cascade of biomarker changes in GRN-related frontotemporal dementia , 2021, Journal of Neurology, Neurosurgery, and Psychiatry.
[3] C. Enzinger,et al. Serum neurofilament light chain , 2020, Neurology: Neuroimmunology & Neuroinflammation.
[4] K. Blennow,et al. Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.
[5] Y. Iturria-Medina,et al. Blood and brain gene expression trajectories mirror neuropathology and clinical deterioration in neurodegeneration. , 2020, Brain : a journal of neurology.
[6] Nick C Fox,et al. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study , 2019, The Lancet Neurology.
[7] David T. Jones,et al. Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration , 2019, Alzheimer's & Dementia.
[8] David T. Jones,et al. Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration , 2019, Alzheimer's & Dementia.
[9] Rogier A. Feis,et al. Gray and white matter changes in presymptomatic genetic frontotemporal dementia: a longitudinal MRI study , 2019, Neurobiology of Aging.
[10] Chun-Hung Yeh,et al. MRtrix3: A fast, flexible and open software framework for medical image processing and visualisation , 2019, NeuroImage.
[11] S. Rombouts,et al. Longitudinal multimodal MRI as prognostic and diagnostic biomarker in presymptomatic familial frontotemporal dementia , 2018, Brain : a journal of neurology.
[12] Rogier A. Feis,et al. Single-subject classification of presymptomatic frontotemporal dementia mutation carriers using multimodal MRI , 2018, NeuroImage: Clinical.
[13] Jennifer M. Nicholas,et al. Presymptomatic white matter integrity loss in familial frontotemporal dementia in the GENFI cohort: A cross‐sectional diffusion tensor imaging study , 2018, Annals of clinical and translational neurology.
[14] James Zou,et al. Exploring patterns enriched in a dataset with contrastive principal component analysis , 2018, Nature Communications.
[15] S. Ourselin,et al. Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study , 2018, Neurobiology of Aging.
[16] Nick C Fox,et al. Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference , 2017, Nature Communications.
[17] J. Rohrer,et al. Imaging and fluid biomarkers in frontotemporal dementia , 2017, Nature Reviews Neurology.
[18] Russell T. Shinohara,et al. Harmonization of cortical thickness measurements across scanners and sites , 2017, NeuroImage.
[19] Alan C. Evans,et al. Multifactorial causal model of brain (dis)organization and therapeutic intervention: Application to Alzheimer’s disease , 2017, NeuroImage.
[20] Ragini Verma,et al. Harmonization of multi-site diffusion tensor imaging data , 2017, NeuroImage.
[21] Howard J. Rosen,et al. Network degeneration and dysfunction in presymptomatic C9ORF72 expansion carriers , 2016, NeuroImage: Clinical.
[22] M. Jorge Cardoso,et al. Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia , 2016, Neurology.
[23] S. Ourselin,et al. Neurofilament light chain: a biomarker for genetic frontotemporal dementia , 2016, Annals of clinical and translational neurology.
[24] A. Boxer,et al. Therapy and clinical trials in frontotemporal dementia: past, present, and future , 2016, Journal of neurochemistry.
[25] Abel Folch-Fortuny,et al. Missing Data Imputation Toolbox for MATLAB , 2016 .
[26] J. Neumann,et al. Validating new diagnostic imaging criteria for primary progressive aphasia via anatomical likelihood estimation meta‐analyses , 2016, European journal of neurology.
[27] S. Mead,et al. Review: An update on clinical, genetic and pathological aspects of frontotemporal lobar degenerations , 2015, Neuropathology and applied neurobiology.
[28] N. Pearce,et al. Neurofilament light chain , 2015, Neurology.
[29] Veronica Redaelli,et al. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis , 2015, The Lancet Neurology.
[30] J. Hodges,et al. Longitudinal white matter changes in frontotemporal dementia subtypes , 2014, Human brain mapping.
[31] Patrizia Rizzu,et al. Structural and functional brain connectivity in presymptomatic familial frontotemporal dementia , 2013, Neurology.
[32] Arno Klein,et al. 101 Labeled Brain Images and a Consistent Human Cortical Labeling Protocol , 2012, Front. Neurosci..
[33] I. Mackenzie,et al. Advances in understanding the molecular basis of frontotemporal dementia , 2012, Nature Reviews Neurology.
[34] Q. Gong,et al. Gray Matter Atrophy in Behavioral Variant Frontotemporal Dementia: A Meta-Analysis of Voxel-Based Morphometry Studies , 2012, Dementia and Geriatric Cognitive Disorders.
[35] Nick C Fox,et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. , 2011, Brain : a journal of neurology.
[36] B. Miller,et al. Classification of primary progressive aphasia and its variants , 2011, Neurology.
[37] C R Jack,et al. Gray and white matter water diffusion in the syndromic variants of frontotemporal dementia , 2010, Neurology.
[38] B. Miller,et al. Neurodegenerative Diseases Target Large-Scale Human Brain Networks , 2009, Neuron.
[39] Chaozhe Zhu,et al. An improved approach to detection of amplitude of low-frequency fluctuation (ALFF) for resting-state fMRI: Fractional ALFF , 2008, Journal of Neuroscience Methods.
[40] John Ashburner,et al. A fast diffeomorphic image registration algorithm , 2007, NeuroImage.
[41] B. Borroni,et al. Looking for Neuroimaging Markers in Frontotemporal Lobar Degeneration Clinical Trials: A Multi-Voxel Pattern Analysis Study in Granulin Disease. , 2016, Journal of Alzheimer's disease : JAD.
[42] Cheng Li,et al. Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.
[43] P. Evans. Therapy and clinical trials. , 2000, Current opinion in lipidology.
[44] Vijaya L. Melnick,et al. Alzheimer’s Dementia , 1985, Contemporary Issues in Biomedicine, Ethics, and Society.